Would love to hear soneone's recaps, thoughts, impressions, any RVX news, competitors, breakthroughs, etc.

Even without a talk or poster, interesting and important conference either way. 

But from Bear's earlier post...

2 presentations found for upcoming ESC 2021 meeting: https://digital-congress.escardio.org/ESC-Congress

Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial

Presenter: Peter Toth (CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease - Baltimore, United States of America)

Bromodomain and extraterminal (BET) protein inhibitor, apabetalone, reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro

Presenter: Dean Gilham (Resverlogix Corp. - Calgary, Canada)